chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On thursday night I started experiencing some tingling in my back. I did not think much of it, but I decided not to go to work. I am a pharmacist so on friday when I went to work I started sweating and was weak I could barely stang. I went home to rest after cosulting with my physician to rest. I went home to rest and stated experiencing tingling and numbness in my left and right arm. I called the health department that gave me the vaccination and they said noone has complained of that side effect. I received the LAIV H1N1. Icalled my physician again who told me to take Benadryl. On saturday I only had tingling on my right arm so I felt more secure and decided not to go to the ER. Around 4 A.M i woke up with no felling on my right arm and a horrible tingling sensation. My husband encouraged me to rest and rubed my arm. When I woke up I could barely walk and was hobling. My whole right side is tingling and numb. I went to the ER where they performed a CT scan and blood work. Everything looked okay so they sent me home to be evaluated by my doctor on Monday and possible referral to a neurologist if I am not improving.
Pt was nervous about getting vaccinated.  Before administering the shot, the pt was told that she had to wait 30 mins after the injection to make sure she doesn't have any reactions to the vaccine.  20 mins after the vaccination, the pharmacy technician told the pharmacist that the pt did not look well while waiting with her husband. The pharmacist then spoke with the patient and husband. The pt was seated and said she had an itchy red hive on her left forearm ( the same arm of the vaccination).  She said she had benadryl and would take them if she needed to.  The pharmacist observed the 2 inch hive, asked the pt to check for more hives on her body and  if she had any other symptoms.  Pt did not. Pt sat for 25 minutes more.  The hive was fading away at that time (45 mins post vaccination).  The pt was told to go to another facility with emergency services if MD clears her for further doses.  MD was informed on the next business day (2 days later).   The MD office left a voicemail stating for the next dose the pt needs to go to a facility capable of treating anaphylaxis on site.
Sever flu like symptoms starting the morning after I received the vaccine. Chills, body aches, fever (99.9), exhaustion, vertigo, & stuffy nose.
Pt received HPV #2 on 1/14/08.  Since has had pain at site + small tender nodule in muscle at site.  No redness or s/s infection.
Patient received varicella vaccine: 1) 12/11/04; 2) 11/29/07; 3) 1/14/08
He started to feel weak to a point that he felt was going to pass out; He started to feel weak to a point that he felt was going to pass out; Fell three times; His legs were completely numbed; He suffered a cut in one of his knees; Bruises on the shoulders; Limping from his injuries; This is a spontaneous report from a contactable consumer (patient's grand parent). A 22-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 26Apr2021 (at the age of 22-years-old) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 26Apr2021, the patient experienced he started to feel weak to a point that he felt was going to pass out, he started to feel weak to a point that he felt was going to pass out, fell three times, his legs were completely numbed, he suffered a cut in one of his knees, bruises on the shoulders and on Apr2021 limping from his injuries. Reportedly, he was not asked to wait for at least 15 minutes. Unaware of any possible reaction, he left the store immediately and drove away. On his way, he started to feel weak to a point that he felt was going to pass out. He doesn't remember how he came to stop the car. At one point, he stepped out of the car on a huge avenue, fell three times as his legs were completely numbed. He suffered a cut in one of his knees, bruises on the shoulders. A couple that was driving by him noticed he was in trouble, stopped and helped him. They gave him water and called the paramedics came in and checked his vitals. Found his vitals ok and released him to get back to our home. I contacted the pharmacy headquarters the day after. They told me they were going to contact him soon, which it has not happened. They made a note of my report as reference. The name of the person I spoke to was I insisted they also contacted the store and let them know of the incident, as in my view didn't follow the expected protocol and put him at risk of a fatal accident. Outcome of the event limping from his injuries was not recovered and for other events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Second dose not administered with 36 days; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not administered with 36 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided No treatment product information was provided
Patient received 4 IM injections with no notable occurrence at the time of administration.  Approximately 10 minutes following vaccination, patient lost consciousness while seated, falling forward and striking her forehead/nose.  She did not have syncopal convulsions.  She was without consciousness for 4-5 seconds.  Upon awakening, patient was able to verbalize the events preceding the syncopal episode.  She was lucid, A and O x 3.  She had no loss of memory immediately preceding or subsequent to the syncopal event.  She had no nausea, vomiting, lethargy, visual disturbance.  Neurological exam was normal.  She was further monitored for a 10 minute time frame during which she had no change in physical exam or symptoms.
dizziness and extreme vertigo; dizziness and extreme vertigo; Arm was bruised; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Arm was bruised), DIZZINESS (dizziness and extreme vertigo) and VERTIGO (dizziness and extreme vertigo) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced CONTUSION (Arm was bruised). On 29-Mar-2021, the patient experienced DIZZINESS (dizziness and extreme vertigo) and VERTIGO (dizziness and extreme vertigo). At the time of the report, CONTUSION (Arm was bruised), DIZZINESS (dizziness and extreme vertigo) and VERTIGO (dizziness and extreme vertigo) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-090507 (Patient Link).
Patient had slight swelling on his left arm within the medial epicondyle area. The patient was vaccinated at 11am, and symptoms appeared at 11:35am. Patient was advised to take ibuprofen, and monitor for any worsening symptoms. Patient was advised to go to the emergency room immediately if symptoms worsen.
Injection site pain causing limited range of motion and weakness in the left shoulder.  Condition has persisted for more than 6 months.
suspected vaccination failure / has had 2 shingle shots and has shingles pretty bad now; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient had 2 Shingle shots and had shingles pretty bad at the time of reporting. The reporter stated that any shingles shit did not prevent it. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Patient woke up in the middle of the night with severe itch.  Negative hives or shortness of breath.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021 at 9:11 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 9:11 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 69.45 years.  Concomitant products were not provided. Number of vials sent to clinic were 19. Vial moved to fridge on 08-Mar-2021 and beyond use date for these vials was reported as 08-Apr-2021. Vial was moved to clinic on 20-Mar-2021.   Batch number 031A21A administered on 20-Mar-2021 underwent temperature excursion with temperature of 34 degrees Fahrenheit at 09:00 am and 37 degrees Fahrenheit at 10:00 am.  On 20-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34 10 AM: 30, 11 AM: 41, 12 AM: 45, 1PM: 44, 2 PM: 44, 3 PM: 44, 4 PM: 44 and 5 PM: 43.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Soreness around injection site (normal) for two days.  On Friday (two days after shot) noticed rash and some swelling about the size of three quarters at injection site.
approx 1 week after vaccine administration, injection site became red and indurated, tender to touch approx 5 inches x 4 inches around.  border drawn around it and it was noted to spread beyond bounds. PCP ordered Keflex antibiotic for treatment
Pt recvd vax 3MAR92 & on 5MAR devel hives; 7MAR severe itching, more hives used DPH; 10MAR seen by MD given med to help itching & for rest; 25MAR seen in ER covered w/hives, feeling pressure in chest;
rash on pt was seen by MD was seen in ER;raised reddened rash over back, abd;few on arms & legs rash on face also;
Patient received first dose of Pfizer vaccine and felt dizzy when walking towards the observation area. Pt had a vasovagal response and was helped to the floor by his father.    Feet were immediately elevated and patient regained consciousness within seconds. Pt reported not eating anything that day, juice and crackers were given to pt. PHN Program Manager encouraged nursing staff to offer snacks to minors reporting that they have not eaten prior to vaccination. PHN Program Manager encouraged pt to notify nurses of 1st dose fainting experience prior to 2nd dose vaccination (at next appointment) and request cot for 2nd dose vaccination and recovery. Pt slowly sat up to snack and reported feeling " fine " after a few minutes. Patient ambulated out of clinic with father after 15 minutes of observation.
GOING DEAF IN ONE EAR; UNBEARABLE RINGING IN MY HEAD; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total, start therapy date were not reported, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced going deaf in one ear, and unbearable ringing in my head. On an unspecified date, the reporter stated that "Can you help me with the three months of he heck I've been through from going deaf in one ear and the unbearable ringing in my head from your safe vaccine." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the going deaf in one ear and unbearable ringing in my head was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220201356-Covid-19 vaccine ad26.cov2.s-going deaf in one ear This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
606 doses were given after expiration date; product stored refrigerator after expiry date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (product stored refrigerator after expiry date) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (product stored refrigerator after expiry date). On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (product stored refrigerator after expiry date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported. On 18-Oct-2021, the vial was placed in the refrigerator. The vial did not had any temperature excursion and the patient had no adverse event. No Treatment medication reported.
As per protocol, patient was given a FLUZONE high dose. No reaction. Approx 8 hours later wife called and said he was vomiting and chills. Advised to go to emergency room.
On an unspecified date, the pt received his 1st dose of Hep-B vaccine. Subsequently, his experienced rash and hives and was admitted to a mental health/residential/intermediate care facility. As of 1/30/01, the outcome of the event was unknown.
Thrombosis (Blood in Stool) with Thrombocytopenia (Platelet count 94 K/uL) TTP based on CBC test & BLOOD CLIDE on Aug 22 2022
4/97 High Temp. In 10/97 High Temp, swollen thumb, stopped using right hand. On 10/31/1997 rash on lower back and 11/4/97 high temp, 11/5/1997 seen and given Motrin and questionable arthritis. On 11/7/1997 right knee swollen and stiff, normal RH count. On 11/13/1997 pt had limp, dx'd with juvenile rheumatoid arthritis and 11/19/1997 right foot swollen on 12/3/1997 back to Naprosyn and Motrin, splint right leg. 12/4/1997 fever, lymph nodes swollen, rash put on antibiotics; 1/4/1997 more blood work and left ankle and toes swollen. On 3/3/98 Lymph nodes still swollen. 5/13/1998 Started on Zantac, 8/18/1998 2nd opinion;taken off motrin, given exercises for heart. 8/24/1998 poly-articullar juvenile arthritis. 8/25/1998 Restarted on Motrin. 12/17/1998 Symptoms started subsiding medication decreased. 6/99 all medication discontinued. 12/5/99 knees, elbow aching, left knee swollen- Naprosyn started, on 2/7/00 surgery included drained left knee and injected with steroids. On 2/17/2000 medication stopped. On 3/13/2000 Stomach aches. 2nd opinion- no meds.
Significant generalized myalgias in pelvis, back and ribs, starting the evening after immunization and continuing several days after. Prolonged discomfort (approximately 5 days) at injection site.
Shortly after vaccine administered patient started to feel swelling and hives which progressed to cover all of upper, lateral left arm.  Patient self treated with Benadryl.
This is a GOOD outcome rather than adverse: nearly 48 hours after receiving my second Pfizer shot, arthritis in my left hip disappeared. I assume this effect is only temporary because it also happened after my first Pfizer shot (4/16/2021, Pfizer ER8731); then, the arthritis pain returned on 4/18 or 4/19. It's nice to not have the pain if only for a little while! I wonder what this might mean for arthritis treatment?
Patient was given a bivalent pfizer 5yr to 12 yr instead of a monovalent pfizer 5yr-11 yr for first dose in primary series
During a mass flu clinic for adults and children I gave a child Fluarix, meant for adults 18 years old and older, by mistake.  No known adverse events.
Patient has a PCI at our facility. When we called that patient to follow up on her visit she told us that she was seen in an ER with a "chemical reaction to the pneumonia shot". She described her symptoms to be aching all over, fever 103.2, back of arm red, swollen and painful. She tells is that she was treated with doxycycline.
This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 19-year-old female patient who received BEXSERO (batch number 149001A, expiry date 30 November 2016). On 9th AUGUST 2016, the patient received BEXSERO (intramuscular). On 9th AUGUST 2016, several hours after receiving BEXSERO, the patient experienced pain in arm, pain in elbow and tenderness. In AUGUST 2016, the patient experienced injection site swelling. The patient was treated with naproxen and steroids nos. On an unknown date, the outcome of the pain in arm, pain in elbow, tenderness and injection site swelling were unknown.  It was unknown if the reporter considered the pain in arm, pain in elbow, tenderness and injection site swelling to be related to BEXSERO. Additional details were provide as follows: This case was previously reported to a doctor. This case was reported by a licensed practical nurse. The reporter stated that, the patient experienced shooting pain up and down her left arm, whole arm tender to touch and very achy particularly around elbow after receiving BEXSERO at 10:04 am in left arm. It was also reported that, there was swelling at the injection site about the size of nickel. The patient was treated with steroids and Naproxen for pain. The reporter would not be administering second vaccination in series. The case is one of the three cases reported by the same reporter.
Chills, nausea, vomiting, diarrhea, headache, muscle aches, fatigue, loss of appetite for approx 36 hrs.
One week after  (1/28) 1st injection, developed a slight cutaneous inflammation and itch in area surrounding injection site.  Increased symptoms over past two days. Treated with  Triamcinolone cream (my RX for atopic dermatitis flares) w/some relief.  My research indicates this has not been cited as an issue for 2nd vaccine and continuing to self evaluate.
Headache; nausea (moderate); pain at injection site (mild); This is a spontaneous report received from a non-contactable physician, the patient. A 61-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: lot number: EL3247) via an unspecified route of administration in the left arm on 22Feb2021 at 09:15 (at the age of 61-year-old) and her second dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: EL3247,) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patients medical history included obesity. Concomitant medications included OZEMPIC 1mg/week, CONTRAVE, PRESERVISION, ALAVERT. The patient was allergic to aspirin. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. On 17Mar2021 at 06:00, the patient experienced headache, moderate nausea and mild injection site pain. The treatment received for the event headache included tylenol. The clinical outcome of the events headache, nausea and injection site pain were reported as recovering.  No follow-up attempts are needed. No further information is expected.
burning back (upper) then arms;extreme weakness, legs then whole body;nauseated;medicinal taste mouth & nose;bone cold-no chills;possible GBS per MD;
Pt received vaccination @ 1845 on 11/8.  Pt presented to ER @  2345 on 11/9 (practitioner filling out this report is  from ER).  Pt with diffuse facial swelling, primarily around BL  orbital regions @ 2230.  No signs of anaphylaxis.  Given 10ml children's Benadryl @ 2300 by parent.  Given PO dexamethasone, observation.  DC home with PMD follow up, strict return precautions.
Patient developed a red rash at injection site about 2 inches long and 1 inch wide. She has been advised to keep it covered and treat with acetaminophen and ice.
On 3/30/18 patient reports swelling, severe pain to site of injection that extends up to her neck and collar bone area. Taking ibuprofen 750mg - 1000mg (states does not help much with the pain).